These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21186694)

  • 21. An investigation into the role of ascorbic acid in renal calculogenesis in albino rats.
    Singh PP; Sharma DC; Rathore V; Surana SS
    J Urol; 1988 Jan; 139(1):156-7. PubMed ID: 3336088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis.
    Chandhoke PS
    Minerva Urol Nefrol; 2005 Mar; 57(1):9-16. PubMed ID: 15944517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin C supplementation and kidney stone risk.
    Pullar JM; Carr AC; Vissers MC
    N Z Med J; 2013 Oct; 126(1384):133-4. PubMed ID: 24162642
    [No Abstract]   [Full Text] [Related]  

  • 24. Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.
    DeFoor WR; Asplin JR; Kollar L; Jackson E; Jenkins T; Schulte M; Inge T
    Surg Obes Relat Dis; 2016 Feb; 12(2):363-7. PubMed ID: 26077697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycine loading and urinary oxalate excretion.
    Hahn RG; Sikk M
    Urol Int; 1994; 52(1):14-6. PubMed ID: 8140673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of dietary oxalate on kidney stone formation.
    Holmes RP; Assimos DG
    Urol Res; 2004 Oct; 32(5):311-6. PubMed ID: 15221245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney stone risk following modern bariatric surgery.
    Gonzalez RD; Canales BK
    Curr Urol Rep; 2014 May; 15(5):401. PubMed ID: 24658828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary and holistic treatment of recurrent calcium oxalate kidney stones: review of literature to guide patient education.
    Flagg LR
    Urol Nurs; 2007 Apr; 27(2):113-22, 143; quiz 123. PubMed ID: 17494450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones: A New Epidemic?
    Assimos DG
    J Urol; 2015 Aug; 194(2):425. PubMed ID: 26195375
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute oxalate nephropathy after a massive intravenous dose of vitamin C.
    Wong K; Thomson C; Bailey RR; McDiarmid S; Gardner J
    Aust N Z J Med; 1994 Aug; 24(4):410-1. PubMed ID: 7980244
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolic syndrome and bariatric surgery in stone disease etiology.
    Tasca A
    Curr Opin Urol; 2011 Mar; 21(2):129-33. PubMed ID: 21191301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stone research on the bench: where we are and where we are going.
    Khan SR
    J Endourol; 2002 Aug; 16(6):413-6. PubMed ID: 12227916
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk Factors for Kidney Stone Formation following Bariatric Surgery.
    Prochaska M; Worcester E
    Kidney360; 2020 Dec; 1(12):1456-1461. PubMed ID: 34085046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence of renal lithiasis.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies of experimental calcium oxalate stones. 2. The preventive effects of phytin and citrate on renal deposition of calcium oxalate induced by ethylene glycol administration].
    Ebisuno S; Morimoto S; Fukatani T; Miyazaki Y; Yasukawa S; Sawada Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):843-9. PubMed ID: 4068425
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary oxalosis due to excess vitamin C intake.
    Nasr SH; Kashtanova Y; Levchuk V; Markowitz GS
    Kidney Int; 2006 Nov; 70(10):1672. PubMed ID: 17080154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.